Sinclair's Esthetics Evolution
This article was originally published in Scrip
Sinclair IS Pharma Plc. has completed the strategic disposal of its non-esthetics business to Alliance Pharma Plc. for a total of £132m upfront in cash along with sales-related royalty payments relating to burn infection product Flammacerium US.